Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Buy
602
+2
+0.3% +$3.18K 0.27% 86
2026
Q1
$792K Hold
600
0.2% 104
2025
Q4
$642K Buy
600
+89
+17% +$92.8K 0.16% 119
2025
Q3
$495K Buy
511
+5
+1% +$3.93K 0.13% 147
2025
Q2
$406K Buy
506
+187
+59% +$134K 0.11% 148
2025
Q1
$211K Buy
319
+277
+660% +$202K 0.07% 206
2024
Q4
$29.1K Buy
42
+37
+740% +$26.6K 0.01% 281
2024
Q3
$4.17K Hold
5
﹤0.01% 307
2024
Q2
$5.11K Hold
5
﹤0.01% 300
2024
Q1
$4.85K Hold
5
﹤0.01% 301
2023
Q4
$3.79K Buy
+5
New +$3.3K ﹤0.01% 290

Other funds holding ASML

Wellington Shields & Co's ASML Position: Q2 2026 in Review

Wellington Shields & Co increased its ASML (ASML) stake by 0.33% in Q2 2026, buying an estimated $3.18K and bringing the position to 602 shares worth $1.2M. The position accounts for 0.27% of the portfolio, ranked #86.

Wellington Shields & Co first reported a position in ASML in Q4 2023 and has held it in 11 quarters since. 2,496 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Wellington Shields & Co held 602 shares of ASML worth $1.2M as of Q2 2026.
  • Wellington Shields & Co bought 2 ASML shares in Q2 2026, an estimated $3.18K.
  • ASML made up 0.27% of Wellington Shields & Co's portfolio in Q2 2026, its #86 holding.
  • Wellington Shields & Co first reported a position in ASML in Q4 2023 and has held it in 11 quarters since.
  • 2,496 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Wellington Shields & Co's 13F filing for Q2 2026, filed 10 Aug 2026.